Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. 1990

M R Shalaby, and A Sundan, and H Loetscher, and M Brockhaus, and W Lesslauer, and T Espevik
Institute of Cancer Research, University of Trondheim, Norway.

The present study was undertaken to further characterize the interaction of monoclonal antibodies (mAbs) against tumor necrosis factor (TNF) receptors with different targets, and to assess their ability to influence TNF effects on U937 and human endothelial cell (HEC) functions. Actions of recombinant TNF-alpha on U937 and HEC were effectively inhibited by Htr-5 and Utr-1, and to a greater extent by a combination of both mAbs. These observations indicate that TNF interaction with antigenically different components of membrane receptors (p55 and p75) represents a crucial step in transduction of signals for TNF toxicity against U937 and TNF activation of HEC functions.

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D018124 Receptors, Tumor Necrosis Factor Cell surface receptors that bind TUMOR NECROSIS FACTORS and trigger changes which influence the behavior of cells. Cachectin Receptors,TNF Receptors,Tumor Necrosis Factor Receptors,Receptors, Cachectin,Receptors, TNF,TNF Receptor,Tumor Necrosis Factor Receptor,Receptor, TNF

Related Publications

M R Shalaby, and A Sundan, and H Loetscher, and M Brockhaus, and W Lesslauer, and T Espevik
January 2001, Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994),
M R Shalaby, and A Sundan, and H Loetscher, and M Brockhaus, and W Lesslauer, and T Espevik
February 1990, The Journal of experimental medicine,
M R Shalaby, and A Sundan, and H Loetscher, and M Brockhaus, and W Lesslauer, and T Espevik
October 1992, The Journal of biological chemistry,
M R Shalaby, and A Sundan, and H Loetscher, and M Brockhaus, and W Lesslauer, and T Espevik
April 1988, Immunology letters,
M R Shalaby, and A Sundan, and H Loetscher, and M Brockhaus, and W Lesslauer, and T Espevik
June 1986, Biochemical and biophysical research communications,
M R Shalaby, and A Sundan, and H Loetscher, and M Brockhaus, and W Lesslauer, and T Espevik
January 1991, Chinese journal of biotechnology,
M R Shalaby, and A Sundan, and H Loetscher, and M Brockhaus, and W Lesslauer, and T Espevik
April 1990, Proceedings of the National Academy of Sciences of the United States of America,
M R Shalaby, and A Sundan, and H Loetscher, and M Brockhaus, and W Lesslauer, and T Espevik
November 2009, P & T : a peer-reviewed journal for formulary management,
M R Shalaby, and A Sundan, and H Loetscher, and M Brockhaus, and W Lesslauer, and T Espevik
January 1987, Journal of immunological methods,
M R Shalaby, and A Sundan, and H Loetscher, and M Brockhaus, and W Lesslauer, and T Espevik
October 1993, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!